Actively Recruiting
Prednisolone Treatment in Acute Interstitial Nephritis
Led by Region MidtJylland Denmark · Updated on 2020-12-30
110
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
Sponsors
R
Region MidtJylland Denmark
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis
CONDITIONS
Official Title
Prednisolone Treatment in Acute Interstitial Nephritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy confirmed acute interstitial nephritis (AIN)
- Clinical suspicion of AIN
- Age over 18 years
- Either plasma creatinine greater than 120 µmol/L or an increase in plasma creatinine greater than 30 µmol/L or more than 50% increase from baseline
- Fertile women are eligible
You will not qualify if you...
- Unable to provide informed consent
- Immunosuppressive treatment including prednisolone within 3 months before biopsy
- Presence of autoimmune disease
- Intolerance to prednisolone
- Pregnancy or breastfeeding
- Active cancer except basal cell carcinoma
- Life expectancy less than 6 months
- Chronic kidney disease stage IV or V
- AIN caused by or accompanied by glomerulonephritis, sarcoidosis, or inherited interstitial kidney disease
- Previous participation in this study
- Development of exclusion criteria during study
- Withdrawal of consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Godstrup Hospital
Herning, Denmark, 7400
Actively Recruiting
Research Team
F
Frank Mose, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here